Results published; researchers call findings exciting but cautious
1 Sep 17 · 6d ago · 1 article · 2 posts · 3 sources · development 1 of 1
The case study was published in a peer-reviewed journal this week. Neurologist Steve Vucic called the results an "exciting first step" while noting it is too early to know if the treatment stops disease progression or cures the condition. Fleur Garton noted that similar antisense therapies could be developed for people with common, rare, or multiple genetic mutations driving ALS.
“the results are an "exciting first step", although it is too early to know whether the treatment could stop disease progression or be a cure”
Steve VucicTrial participant First patient treated with mutation-targeting RNA therapy for ALSSteve Vucic Neurologist and ALS researcher, University of SydneyFleur Garton Neurological disease researcher, University of Queensland
The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump
Reported in the same hours no headline names this development itself — these 1 claim were published in its stretch
-
first by Nature, 5d ago · also Nature News
What people said 1 voice · verbatim
-
E
'Unlike typical gene therapy, which alters a person’s genes to treat a genetic disease, antisense oligonucleotide [RNA] therapy, uses short strands of genetic material to target RNA produced by the gene and reduce how much protein is made.' Looking for good news. Advances in RNA science & med.
All 1 developments of Man with rare ALS improves after first-ever RNA therapy… →
NewswiresMastodonBlueskyGoogle NewsReddit